Treatments & Interventions
Mannitol hexanitrate
substance
Ethacrynate sodium
substance
Torsemide
substance
Ethacrynic acid
substance
Spironolactone
substance
Furosemide
substance
Human serum albumin
substance
Bumetanide
substance
Amiloride
substance
Amiloride hydrochloride
substance
Medium chain triglycerides
substance
Icodextrin
substance
Albumin human
substance
Amiloride hydrochloride anhydrous
substance
Clinical Trials
Recent Trials
DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis
Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis
Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis
Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal
Spironolactone Versus Spironolactone Plus Furosemide (SVSSF)
Research Evidence
Peer-reviewed studies linked via MeSH term "Ascites" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Related Conditions
Quick Facts
- SNOMED CT
- 389026000
- UMLS CUI
- C0003962
- Fully Specified Name
- Ascites (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Known Treatments
- 14
- Clinical Trials
- 12
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.